Boomerang Medical is a women-led bioelectronic medical company that was granted breakthrough device designation from the FDA for its bioelectronic IBD solution.
“The most fascinating aspect of this study is the possibility of managing IBD simply by stimulating the patient’s autonomic system to release anti-inflammatory mediators,” Marco Zoccali, MD, a principal investigator for the trial at Columbia, said in an April 17 press release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
